Mary Territo, M.D.

Work Titles
UCLA Professor, Medicine Co-Director, Bone Marrow/Stem Cell Transplantation Professor, Hematology-Oncology Co-Director, Bone Marrow / Stem Cell Transplantation Program Member, JCCC Cancer and Stem Cell Biology Program Area Member, Oncology Treatment Center at UCLA
M.D., Wayne State University School of Medicine, 1968
1971 - 1973 Harbor - UCLA Medical Center
1968 - 1969 Parkland Memorial Hospital
1969 - 1971 Parkland Memorial Hospital
1974 American Board of Internal Medicine
1972 American Board of Internal Medicine

Contact Information:

Work Email Address:



Work Address:

42-121 CHS
CAMPUS - 167817


A selected list of publications:

Winston DJ, Emmanouilides C, Bartoni K, Schiller GJ, Paquette R, Territo MC   Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment Blood. , 2004; 104(5): 1581; author reply 1582.
Baum LG, Blackall DP, Arias-Magallano S, Nanigian D, Uh SY, Browne JM, Hoffmann D, Emmanouilides CE, Territo MC, Baldwin GC   Amelioration of graft versus host disease by galectin-1 Clinical immunology (Orlando, Fla.) , 2003; 109(3): 295-307.
Collisson EA, Lashkari A, Malone R, Paquette R, Emmanouilides C, Territo MC, Schiller GJ   Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. , 2003; 17(11): 2183-8.
Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC   Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial Annals of internal medicine. , 2003; 138(9): 705-13.
Winston DJ, Yeager AM, Chandrasekar PH, Snydman DR, Petersen FB, Territo MC   Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. , 2003; 36(6): 749-58.

Does this profile need updating? Contact Us